The challenge of ensuring equity in mass deworming programmes by Jourdan, P. M. & Tediosi, F.
Comment
www.thelancet.com/lancetgh   Vol 7   November 2019 e1468
The challenge of ensuring equity in mass deworming 
programmes
Preventing neglected tropical diseases (NTDs) through 
mass treatment of at-risk populations provides a cost-
effective way of improving health equity in endemic 
countries.1 Considerable funds and human resources are 
invested in mass deworming of children and women of 
childbearing age in areas endemic of soil-transmitted 
helminthiasis; that is, infections with parasites, such 
as roundworms, whipworms, and hookworms.2 
Ministries of Health have together with UN agencies, 
philanthropic foundations, pharmaceutical companies, 
and non-governmental organisations, put in place 
large-scale programmes for dispatching deworming 
medication across vast areas of the world, with 
inherent challenges related to logistics, infrastructure, 
human resources, sociocultural issues, and even armed 
conflict and unrest. Tremendous advances have been 
made, and in 2017, close to 750 million people were 
reached yearly.3
Nathan Lo and colleagues4 have estimated the equity 
of access to such deworming by analysing Demographic 
and Health Surveys data for over 820 000 children 
aged 1–4 years across 50 low-income and middle-
income countries. The study includes analyses of data 
collected between 2004 and 2017, on the basis of 
mother-reported access to deworming for preschool 
age children. The findings suggest that deworming 
programmes did not consistently provide deworming 
equitably across geographical locations and wealth 
classes, indicating that children of wealthier families 
were more likely to be treated than others. The results 
also apply to countries that, in line with the WHO goal, 
have reported more than 75% national coverage.
The study draws attention to the need to assess the 
equity of access to deworming, in order to further 
strengthen and improve the efficacy and cost-
effectiveness of such programmes. Although it has been 
argued that an average NTD service coverage indicator 
might serve as a measure of equity in the progress 
towards universal health coverage,5 NTD specific 
equity metrics have yet to be included in regular NTD 
programme monitoring and evaluation. As such, Lo 
and colleagues’ article is an important addition to the 
literature on global health equity.
The success of large public health programmes 
depends on a complex interdependency between 
the many stakeholders involved in programme 
funding and organisation, including on-the-ground 
staff, and the many intermediaries involved in 
programme logistics. Such interdependency, as well 
as the relatively limited financial and human resources 
typically available for such programmes, has the 
potential to affect the way in which deworming is 
provided, and subsequently reported, evaluated and 
monitored. Various other factors associated with both 
supply and demand sides of deworming programmes, 
could also explain the findings by Lo and colleagues, 
including the motivation of health-care workers 
and community volunteers at the end of the supply 
chain. However, although some reports suggest that 
mismatches can occur between reported programme 
activities and actual treatments,6 other data 
suggest that sufficiently funded and well-organised 
programmes can be successful in providing equitable 
preventive chemotherapy.7
Importantly, the study by Lo and colleagues found 
a correlation between deworming and vitamin A 
supplementation and three doses of the diphtheria-
tetanus-pertussis vaccine. This finding indicates 
that key to addressing the challenge of equitable 
deworming will lie in strengthening integrated 
public health services, in line with the Sustainable 
Development Goal of universal health coverage 
by 2030.
Further research is needed to determine whether 
the findings by Lo and colleagues might be 
supported by other studies, and whether the results 
are representative also for other age groups. Also, 
it remains unclear how simple and pragmatic the 
use of the suggested equity index might be in 
a programmatic context, and therefore how to 
accurately measure, assess, and address equitable 
access to mass deworming and, potentially, other NTD 
programmes.8 If the authors’ findings do hold up, the 
question is whether there is room for readjusting NTD 
programmes to further improve access to deworming 
of those most in need.
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